Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus sampling-time error study in pediatric nephrotic syndrome
ChiCTR1900022724Phase 4Not yet recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- May 2019
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tacrolimus in nephrosis, sponsored by Children's Hospital, Zhejiang University School of Medicine. Primary endpoint: Sampling-time error induced concentration bias. Planned start May 2019; status: not yet recruiting.
02
Drugs
tacrolimus
03
Conditions
nephrosis
Beyond the preview
Go deeper on ChiCTR1900022724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022724.